The Rough Guide to Health/Care Consumers in 2025: The 2025 Health Populi TrendCast
At this year-end time each year, my gift to Health Populi readers is an annual “TrendCast,” weaving together key data and stories at the convergence of people, health care, and technology with a look into the next 1-3 years. If you don’t know my work and “me,” my lens is through health economics broadly defined: I use a slash mark between “health” and “care” because of this orientation, which goes well beyond traditional measurement of how health care spending is included in a nation’s gross domestic product (GDP); I consider health across the many dimensions important to people, addressing physical,
National Healthcare Spending in the U.S. Was Nearly $5 Trillion (with a “T”) in 2023 – New Data from CMS
What would $5 trillion be valued around the world or on the stock market? The economy of Germany was gauged around $5 trillion in 2024. India could be the world’s 3rd largest economy by 2026 valued at $5 trillion. Nvidia could be a $5 trillion company in 2025, as could Amazon. But today we report out the latest data from the Centers for Medicare and Medicaid Services (CMS) that national health spending in America reached $4.9 trillion in 2023. The full report on national health expenditures (NHE) in the U.S. was published today in Health Affairs, which came off embargo
What Stays True for U.S. Health Care Post #Election2024 (1) – Consumers’ Dissatisfaction with Drug Prices
For health care, there are many uncertainties as we reflect, one week after the 2024 U.S. elections, on probably policy and market impacts that we can expect in 2025 and beyond. In today’s Health Populi post, I’ll reflect on the first of several certainties we-know-we-know about U.S. health citizens and key factors shaping the American health ecosystem. In this first of several posts on “What Stays True for U.S. Health Care Post #Election2024,” I’ll focus on U.S. consumer dissatisfaction with drug prices — across political party identification. Let’s set the context with data from a recently-published
“People will seek wellness, peace and healing” – Reading the GWI Future of Wellness Report, 2024 Trends
Healthy eating and weight loss, personal care and beauty, exercise and physical activity, and wellness tourism are the four biggest components of the world’s wellness economy, quantified in The Future of Wellness, 2024 Trends, the perennial report from the Global Wellness Institute (GWI). Here’s the bubble chart, which I’ve updated with the 2025 data so we get a sense of what the coming year will bring for the eleven total segments that make up the global wellness market. The fine print of the projections for these areas identifies the annual growth rates for
The Health Insurance Premium for a Family Averages $25,572 in 2024 – KFF’s Annual Update on Employer-Sponsored Benefits
The premium for employer-sponsored health plans grew by 6-7% between 2023 and 2024, according to the report on Employer Health Benefits 2024 Annual Survey from the Kaiser Family Foundation, KFF’s 26th annual study into U.S. companies’ spending on workers’ health care. In 2024 the average annual health insurance premium for family coverage is $25,572, split by 75% covered by the employer (just over $19,000) and 25% borne by the employee ($6,296), shown in the first chart from the report. The nearly $26K family premium is the average across all plan types in the
Obesity is a Public Health Epidemic in the U.S. — The Case for GLP-1 Coverage, Affordability and Equity
“If the U.S. were sensible, weight management would be treated as a public health issue,” David Cutler writes in the JAMA Health Forum dated August 15, 2024. Dr. Cutler, distinguished economics professor at Harvard, talks about “the pathology of U.S. health care” citing the example of weight loss medications — in short, the uptake of GLP-1 drugs to address Type 2 diabetes first, and subsequently obesity. Dr. Cutler notes that the price of these drugs in the U.S. “far exceeds” that of other countries: specifically, 9 times that of the prices in Germany and the Netherlands
Americans Who Perceive Negative Medical Treatment Due to Weight, Insurance Status, and Identity Metrics – YouGov Insights
Millions of Americans believe they have been treated negatively by a physician due to their weight, insurance status, physical appearance and/or state of mental health, according to a YouGov poll published August 6, 2024. To gauge U.S. health citizens’ perceptions of fair and unfair treatment in the health care system, YouGov conducted this research among 1,200 U.S. adults 18 and over online in late June 2024. The first bar chart arrays various identity characteristics describing patients: we see that weight is by far the top characteristic putting the person at-risk for being
Consumers Demand Foods That Are Healthy AND Delicious – and Some Health Equity Implications
The most common food-eating styles practiced by U.S. consumers are low sugar/diabetic diets, low-calorie, dairy-free, anti-inflammatory, and gluten-free, ccording to the Midyear Trends update from Datassential. In their update on the food trends entering the second half of 2024, Datassential offered several insights on consumers and food-as-medicine in a section called the Health Check-Up. These trends are shaping consumers’ food demands in both their grocery shopping preferences (for food consumed in the home) as well as their eating-out ordering strategies — where 35% of consumers want to see menu offerings with foods that are
The Cost of GLP-1 Drugs on Payers’ Minds as Nearly 1/3rd of U.S. Consumers Could Become Users
With 70 different clinical trials for GLP-1 drugs in process with the FDA, payers — and other stakeholders in the health care ecosystem — have the semaglutide-SENSE top of mind, based on my ongoing updating of this fast-moving market space. For overall market context on pace-of-growth in adoption, check out this chart from a JAMA Health Forum research letter on Prescription Fills for Semaglutide Products by Payment Method, published August 2nd. The study was based on the IQVIA National Prescription Audit PayerTrak data which captures 92% of Rx’s filled at retail pharmacies in
What’s Expected to Drive Up Health Plan Costs in 2025: GLP-1s, Behavioral Health, and Inflationary Pressures for Hospitals and Doctors – PwC’s Behind the Numbers 2025
The U.S. Bureau of Labor Statistics had good news for American consumers long-facing inflation for household spending over the past couple of years, announcing on July 11, 2024, that the general consumer price index (CPI) fell, lowering real prices for people buying airline tickets, used cars and trucks, communication, and petrol to fill auto tanks. That positive economic news did not extend to medical care and personal care, the BLS reported, whose costs increased by 3.3% and 3.2%, respectively. (Motor vehicle insurance costs grew a whopping 19.5% in the report, FYI). Following the
Most Americans Follow an Eating Pattern in Search of Energy, Protein, and Well-Being – With Growing Financial Stress: A Food as Medicine Update
Most Americans follow some kind of eating regime, seeking energy, more protein, and healthy aging, according to the annual 2024 Food & Health Survey published this week by the International Food Information Council (IFIC). But a person’s household finances play a direct role in their ability to balance healthful food purchases and healthy eating, IFIC learned. In this 19th annual fielding of this research, IFIC explored 3,000 U.S. consumers’ perspectives on diet and nutrition, trusted sources for food information, and new insights into peoples’ views on the GLP-1 weight-loss drugs and the growing sense
The Thematic Roadmap for AHIP 2024: What the Health Insurance Conference Will Cover
Health insurance plans make mainstream media news every week, whether coverage deals with the cost of a plan, the cost of out-of-network care, prior authorizations, or cybersecurity and ransomware attacks, among other front-page issues. This week, AHIP (the acronym for the industry association of America’s Health Insurance Plans) is convening in Las Vegas for its largest annual 2024 meeting. We expect at least 2,400 attendees registered for the meeting, and they’ll not just be representing the health insurance industry itself; folks will attend #AHIP2024 from other industry segments including pharmaceuticals, technology, hospitals and health systems, and the investment and financial services
GLP-1s’ direct and indirect impacts on health care and consumer goods – Jane speaks with Bloomberg BNN
Today, I spoke live with Paul Bagnell, news anchor with Bloomberg BNN, on the topic of the GLP-1 agonists and their impact on health care, industries beyond health and medicine, and consumers. In this post, I’ll share with you some of the plotline for our discussion. Gallup polled U.S. adults in March to gauge their experience with injectable weight loss drugs, the results published earlier this week. The first chart tells us that 6% of people have used these drugs, and 3% were doing so in March. Consumers using the meds were more
Prescriptions Are Up, Health Services Utilization Down, and GLP-1s Are a Major Growth Driver: IQVIA’s 2024 Update
In the past year, the growth of prescription drug utilization and spending has much to do with the use of GLP-1 agonists to treat diabetes and obesity, along with immunology therapy, and lipid meds, along with specialty medicines now accounting for over half of spending — up from 49% in 2018. This update comes from The Use of Medicines in the U.S. 2024 from the IQVIA Institute for Human Data Science. The annual report details trends in health services utilization, the use of prescription drugs, patient financing of those costs, the drivers underpinning the medicines spending, and an outlook to 2028.
Telehealth Legislation Passes Ways & Means, As GLP-1s Are Fast-Meshing with Telemedicine in the Marketplace
Yesterday, the U.S. House Committee on Ways and Means passed six pieces of legislation that would bolster telehealth in the U.S. for the next two years, assuring several aspects of access for health citizens across the country. “One of our top priorities on this Committee is helping every American access health care in the community where they live, work, and raise a family,” Committee Chairman Jason Smith (R-Mo.) explained in his introductory statement. Being from Missouri, Chairman Smith is especially keen on the role virtual care and telehealth can play to expand access to the under-served in the U.S. “In rural
Considering Equity and Consumer Impacts of GLP-1 Drugs – A UBS Economist Weighs In
Since the introduction of GLP-1 drugs on the market, their use has split into two categories: for obesity and “recreationally,” according to the Chief Economist with UBS (formerly known as Union Bank of Switzerland). Paul Donovan, said economist, discusses The economics of getting thin in his regularly published comment blog. “These different uses have different economic consequences,” Donovan explains: Obese patients who use GLP-1s should become more productive employees, Donovan expects — less subject to prejudice, and less likely to be absent from work. While so-called recreational GLP-1 consumers may experience these
I was invited to be a Judge for the upcoming CES 2025 Innovation Awards in the category of digital health and connected fitness. So grateful to be part of this annual effort to identify the best in consumer-facing health solutions for self-care, condition management, and family well-being. Thank you, CTA!
Thank you Team Roche for inviting me to brainstorm patients as health citizens, consumers, payers, and voters in the Healthcare Transformers series.
For the past 15 years, the annual CES conference in Las Vegas has been my go-to meeting for updating my research and network in digital health and consumer-facing electronics that people find meaningful for their well-being, families, and home lives. I'll be back in Vegas in January for a full week of Media Days, one-on-one meetings, and speaking about my perspectives on health consumers.